Combined cisplatin-based chemoembolization and radiation therapy for hepatocellular carcinoma invading the main portal vein

Sae Rom Chung, Jin Hyoung Kim, Hyun Ki Yoon, Gi Young Ko, Dong Il Gwon, Ji Hoon Shin, Ho Young Song, Heung Kyu Ko, Sang Min Yoon

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Purpose To evaluate the safety and survival outcome of chemoembolization plus radiation therapy (RT) in patients with hepatocellular carcinoma (HCC) with main portal vein (PV) tumor thrombosis. Materials and Methods This retrospective study evaluated 151 patients with HCC and main PV involvement (101 with Child-Pugh class A liver function and 50 with Child-Pugh class B liver function) treated with combined cisplatin-based chemoembolization and RT. Medical records, imaging, and laboratory studies were reviewed, and complications, survival, and mortality rates were determined. Results After chemoembolization, major complications occurred in 19.9% of patients, with the rate of major complications significantly higher in Child-Pugh class B cases than in Child-Pugh class A cases (32% vs 13.9%; P =.016). The 30-day mortality rate was 0.7%. One hundred forty-seven patients received adjuvant RT an average of 17.4 days after chemoembolization for main PV tumor thrombosis. Adjuvant RT could not be performed in four patients because of intolerance of the initial chemoembolization. There were no major complications after RT. The objective tumor response at 6 months was 25.2%, with a median survival of 12 months (14 mo in Child-Pugh class A cases and 8 mo in Child-Pugh class B cases). Patients with Child-Pugh class B liver function with extrahepatic metastases, no tumor response, and absence of second-line sorafenib treatment had poor survival. Conclusions Chemoembolization combined with RT improves survival, with a median survival of 12 months in patients with HCC with main PV involvement.

Original languageEnglish (US)
Pages (from-to)1130-1138
Number of pages9
JournalJournal of Vascular and Interventional Radiology
Volume26
Issue number8
DOIs
StatePublished - Aug 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Combined cisplatin-based chemoembolization and radiation therapy for hepatocellular carcinoma invading the main portal vein'. Together they form a unique fingerprint.

  • Cite this